Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03041181
Title Docetaxel Plus Nivolumab or Docetaxel Alone in Patients With Advanced Non-squamous NSCLC Previously Treated With Nivolumab
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nasser Hanna, M.D.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.